Back to search

Article

Plasma Amyloid-β Oligomerization Assay as a Pre-Screening Test for Amyloid Status

2020-12-11

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>We assessed the performance of plasma amyloid oligomerization tendency (OAβ) as a marker for abnormal amyloid status. Additionally, we examined long-term storage effects on plasma OAβ. <bold>Methods:</bold> We included 399 subjects regardless of clinical diagnosis from the Amsterdam Dementia Cohort and European Medical Information Framework for AD project (age:6...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
db061d47-75cd-5be4-9078-0b3175a7574d
DOI
10.21203/rs.3.rs-125101/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Plasma Amyloid-β Oligomerization Assay as a Pre-Screening Test for Amyloid StatusDOI 10.21203/rs.3.rs-125101/v1
Development and clinical validation of blood-based multibiomarker models for the evaluation of brain amyloid pathologySemantic proximity
Prediction of amyloid PET positivity via machine learning algorithms trained with EDTA-based blood amyloid-β oligomerization dataSemantic proximity
A plasma biomarker panel for detecting early amyloid-β accumulation and its changes in middle-aged cognitively unimpaired individuals at risk for Alzheimer’s diseaseSemantic proximity
Definition of a threshold on the plasma Aβ42/Aβ40 ratio measured by single-molecule array to predict the amyloid status of individuals without dementiaSemantic proximity
Comparison of plasma soluble and extracellular vesicles-associated biomarkers in Alzheimer’s Disease patients and cognitively normal individualsSemantic proximity
Discernment of cerebral amyloid and cognitive status using ultrasensitive blood biomarkers collected with a non-traditional anticoagulantSemantic proximity
Comparative analytical performance of multiple plasma Aβ42 and Aβ40 assays and their ability to predict positron emission tomography amyloid positivity.Semantic proximity
Longitudinal Amyloid-β PET in Atypical Alzheimer's Disease and Frontotemporal Lobar Degeneration.Semantic proximity
A Specific Enzyme-Linked Immunosorbent Assay for Measuring β-Amyloid Protein Oligomers in Human Plasma and Brain Tissue of Patients With Alzheimer DiseaseSemantic proximity
Biomarker Variability Limits Individualized Amyloid Time Estimation in Alzheimer DiseaseSemantic proximity
Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assaySemantic proximity
Amyloid blood biomarker detects Alzheimer's diseaseSemantic proximity
Select a neighboring publication to make it the new centre.